234 related articles for article (PubMed ID: 38762512)
1. Upregulated ECM genes and increased synaptic activity in Parkinson's human DA neurons with PINK1/ PRKN mutations.
Tripathi U; Rosh I; Ben Ezer R; Nayak R; Hussein Y; Choudhary A; Djamus J; Manole A; Houlden H; Gage FH; Stern S
NPJ Parkinsons Dis; 2024 May; 10(1):103. PubMed ID: 38762512
[TBL] [Abstract][Full Text] [Related]
2. The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis.
Zhou ZD; Saw WT; Ho PGH; Zhang ZW; Zeng L; Chang YY; Sun AXY; Ma DR; Wang HY; Zhou L; Lim KL; Tan EK
Cell Mol Life Sci; 2022 Nov; 79(12):599. PubMed ID: 36409355
[TBL] [Abstract][Full Text] [Related]
3. Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease.
Kim J; Daadi EW; Oh T; Daadi ES; Daadi MM
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360174
[TBL] [Abstract][Full Text] [Related]
4.
Zhou Y; Liu Y; Kang Z; Yao H; Song N; Wang M; Song C; Zhang K; Ding J; Tang J; Hu G; Lu M
Autophagy; 2023 Sep; 19(9):2520-2537. PubMed ID: 37014258
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism.
Borsche M; König IR; Delcambre S; Petrucci S; Balck A; Brüggemann N; Zimprich A; Wasner K; Pereira SL; Avenali M; Deuschle C; Badanjak K; Ghelfi J; Gasser T; Kasten M; Rosenstiel P; Lohmann K; Brockmann K; Valente EM; Youle RJ; Grünewald A; Klein C
Brain; 2020 Oct; 143(10):3041-3051. PubMed ID: 33029617
[TBL] [Abstract][Full Text] [Related]
6. Rare and novel variants of PRKN and PINK1 genes in Vietnamese patients with early-onset Parkinson's disease.
Ton ND; Thuan ND; Thuong MTH; Ngoc TTB; Nhung VP; Hoa NTT; Nam NH; Dung HT; Son ND; Ba NV; Bac ND; Tai TN; Dung LTK; Hung NT; Duong NT; Ha NH; Hai NV
Mol Genet Genomic Med; 2020 Oct; 8(10):e1463. PubMed ID: 32856414
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-Endoplasmic Reticulum Contact Sites Dynamics and Calcium Homeostasis Are Differentially Disrupted in PINK1-PD or PRKN-PD Neurons.
Grossmann D; Malburg N; Glaß H; Weeren V; Sondermann V; Pfeiffer JF; Petters J; Lukas J; Seibler P; Klein C; Grünewald A; Hermann A
Mov Disord; 2023 Oct; 38(10):1822-1836. PubMed ID: 37449534
[TBL] [Abstract][Full Text] [Related]
8. Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson's disease patients.
Rosh I; Tripathi U; Hussein Y; Rike WA; Djamus J; Shklyar B; Manole A; Houlden H; Winkler J; Gage FH; Stern S
NPJ Parkinsons Dis; 2024 Feb; 10(1):38. PubMed ID: 38374278
[TBL] [Abstract][Full Text] [Related]
9. Mutation Analysis of Consanguineous Moroccan Patients with Parkinson's Disease Combining Microarray and Gene Panel.
Bouhouche A; Tesson C; Regragui W; Rahmani M; Drouet V; Tibar H; Souirti Z; Ben El Haj R; Bouslam N; Yahyaoui M; Brice A; Benomar A; Lesage S
Front Neurol; 2017; 8():567. PubMed ID: 29163333
[TBL] [Abstract][Full Text] [Related]
10. Gene-based burden analysis of damaging private variants in PRKN, PARK7 and PINK1 in Parkinson's disease cohorts of European descent.
Hu J; Waters CH; Spiegelman D; Fon EA; Yu E; Asayesh F; Krohn L; Saini P; Alcalay RN; Hassin-Baer S; Gan-Or Z; Krainc D; Zhang B; Bustos BI; Lubbe SJ;
Neurobiol Aging; 2022 Nov; 119():136-138. PubMed ID: 36305379
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease.
Trinh J; Hicks AA; König IR; Delcambre S; Lüth T; Schaake S; Wasner K; Ghelfi J; Borsche M; Vilariño-Güell C; Hentati F; Germer EL; Bauer P; Takanashi M; Kostić V; Lang AE; Brüggemann N; Pramstaller PP; Pichler I; Rajput A; Hattori N; Farrer MJ; Lohmann K; Weissensteiner H; May P; Klein C; Grünewald A
Brain; 2023 Jul; 146(7):2753-2765. PubMed ID: 36478228
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
[TBL] [Abstract][Full Text] [Related]
13. Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing.
Chen CX; You Z; Abdian N; Sirois J; Shlaifer I; Tabatabaei M; Boivin MN; Gaborieau L; Karamchandani J; Beitel LK; Fon EA; Durcan TM
Stem Cell Res; 2022 Jul; 62():102806. PubMed ID: 35561458
[TBL] [Abstract][Full Text] [Related]
14. Neuropathological findings in PINK1-associated Parkinson's disease.
Nybø CJ; Gustavsson EK; Farrer MJ; Aasly JO
Parkinsonism Relat Disord; 2020 Sep; 78():105-108. PubMed ID: 32814227
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons.
Yokota M; Kakuta S; Shiga T; Ishikawa KI; Okano H; Hattori N; Akamatsu W; Koike M
Mol Brain; 2021 Mar; 14(1):58. PubMed ID: 33757554
[TBL] [Abstract][Full Text] [Related]
16. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
17. Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe.
Milanowski ŁM; Lindemann JA; Hoffman-Zacharska D; Soto-Beasley AI; Barcikowska M; Boczarska-Jedynak M; Deutschlander A; Kłodowska G; Dulski J; Fedoryshyn L; Friedman A; Jamrozik Z; Janik P; Karpinsky K; Koziorowski D; Krygowska-Wajs A; Jasińska-Myga B; Opala G; Potulska-Chromik A; Pulyk A; Rektorova I; Sanotsky Y; Siuda J; Sławek J; Śmiłowska K; Szczechowski L; Rudzińska-Bar M; Walton RL; Ross OA; Wszolek ZK
Parkinsonism Relat Disord; 2021 May; 86():48-51. PubMed ID: 33845304
[TBL] [Abstract][Full Text] [Related]
18. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.
Akundi RS; Huang Z; Eason J; Pandya JD; Zhi L; Cass WA; Sullivan PG; Büeler H
PLoS One; 2011 Jan; 6(1):e16038. PubMed ID: 21249202
[TBL] [Abstract][Full Text] [Related]
19. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.
Franco R; Rivas-Santisteban R; Navarro G; Pinna A; Reyes-Resina I
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924963
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
